Read More Pharma Industry News Astellas Pharma to acquire avacincaptad pegol developer Iveric Bio for $6bn Japanese pharma company Astellas Pharma has agreed to acquire Nasdaq-listed Iveric Bio in an all-cash deal worth around… byPallavi MadhirajuMay 1, 2023